Parenteral iron supplementation in patients with end stage renal disease.
At Winthrop-University Hospital, implementation of the National Kidney Foundation's Dialysis Outcome Quality Initiative (NKF-DOQI) is guided by the principles of reengineering. On the basis of this model, anemia management is entrusted to a process owner. This advanced practice nurse is empowered with the responsibility of managing anemia and evaluated on his/her success in attaining predetermined quality standards-including ongoing patient satisfaction. This article examines use of the process owner position to evaluate, implement, and proactively manage anemia-related outcomes.
Vogel
S C
SC
South Valley Regional Dialysis Center, Inc., Encino, CA, USA.
D018798:Anemia, Iron-Deficiency / Q000188:drug therapy* / Q000209:etiology; D004921:Erythropoietin / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D058085:Iron Compounds / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000150:complications*; D006435:Renal Dialysis
D058085:Iron Compounds; D004921:Erythropoietin